Intrinsiqs

Is Arcturus Therapeutics Holdings Inc. overvalued?

Arcturus Therapeutics Holdings Inc. (ARCT) — key valuation metrics and fundamentals.

No verdict
Price
$8.36
Fair value
—
Current P/E
—
Normal P/E
—
Market cap
$241.0M
Dividend yield
0.0%
Return on equity
-46.8%
Sector
Healthcare

See the full interactive analysis →

Fair value compares ARCT's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 12 Nov 2026.